Found 0 matching trials
Sequential FOLFOX-HAIC-TACE Plus Sintilimab-Bevacizumab Neoadjuvant Therapy Versus Direct Resection in Resectable High-Risk Recurrence Hepatocellular Carcinoma PHASE1 This study is designed to evaluate the efficacy and safety of sintilimab-be...
Show More Location
Multiple Locations
Learn More & Join Trial
Chemo-embolization for Head and Neck Cancer PHASE2 The study will evaluate whether adjuvant chemo-embolization increases progr...
Show More Location
University of Alabama at Birmingham
Learn More & Join Trial
Sorafenib and Micro-therapy Guided by Primovist Enhanced MRI in Patients With Inoperable Liver Cancer PHASE2 The purpose of this study is to evaluate Sorafenib and local microtherapy g...
Show More Location
University of Magdeburg
Learn More & Join Trial
Interest of elastoFRM With Force Measure by MRI on Patients With Hepatocellular Cancer NA FORCE project aims to measure actives forces of malignant tumor by magnetic...
Show More Learn More & Join Trial
CIRSE Registry for LifePearl Microspheres N/A The application of transarterial chemoembolisation (TACE) using LifePearl M...
Show More Location
CIRSE Cardiovascular and Interventional Radiological Society of Europe
Learn More & Join Trial
Lenvatinib Plus TACE Versus Sorafenib Plus TACE for HCC With PVTT PHASE4 Hepatocellular carcinoma (HCC) is the fourth most common cancer in China, w...
Show More Location
Beijing Ditan Hospital, Capital Medical University
Learn More & Join Trial
Role of DEB-TACE Versus c-TACE in Treatment of HCC EARLY_PHASE1 Hepatocellular carcinoma (HCC) is listed as the sixth most common cancer wo...
Show More Location
Sohag University Hospital
Learn More & Join Trial
Chemoembolisation of Non Resectable, Non Metastatic Hepatocellular Carcinomas PHASE1 The purpose of this study is to determine the maximal tolerated dose of ida...
Show More Location
Centre Hospitalier Universitaire de DIJON
Learn More & Join Trial
Lenvatinib, Sintilimab, and DEB-TACE With/Without HAIC for HCC >7 cm With PVTT PHASE2 This study is conducted to evaluate the efficacy and safety of lenvatinib p...
Show More Location
The Second Affiliated Hospital of Guangzhou Medical University
Learn More & Join Trial
A Multicenter, Prospective Study of Perioperative Finotonlimab Combined With Bevacizumab in Resectable Hepatocellular Carcinoma Patients With High-Risk Factors for Recurrence NA For patients with early- to mid-stage hepatocellular carcinoma (HCC), the f...
Show More Status
Active Not Recruiting
Learn More & Join Trial